Paroxetine
 
German Version French Version
 

Paroxetine (3S,4R)-4-(4-Fluorphenyl)-3-{[3,4-methylendioxy)phenoxy]methyl}piperidin, C19H20FNO3, MW 329,37 g/mol

Selective Serotonin Reuptake Inhibitor (SSRI)

Trade Mark: Paxil®, Seroxat®, Tagonis®

 

Application

Treatment of depressive illnes, obsessive-compulsive disorder, panic disorder, social phobia, post-traumatic stress disorder, generalised anxiety disorder. Contraindicated for patients under 18 years of age (high suicide risk)

Interactions

Do not use with MAO inhibitors, because of the danger of a Serotonine syndrome.

Adverse Effects

Especially at the beginning, nausea can occur. When setting off, reduce dose slowly, increased risk of suicides.

Analytics

The determination of Paroxetine can take place after extraction by means of HPLC/DAD. Therapeutic levels: 0.01-0.05 µg/ml.

Overview SSRI

Overview Antidepressiva

Custom Search

 

 

 

Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ